SurgoCap Partners LP: CARPENTER TECHNOLOGY CORP (CRS): Quarterly 13F Position History
As of Q2 2026, SurgoCap Partners LP reported 686,473 shares of CARPENTER TECHNOLOGY CORP (CRS), worth $423.4M and representing 13.7% of its 13F equity book. Quarter-over-quarter share count change: 510,428 (-42.6%) . The position first appeared in Q3 2024 and has been disclosed across 8 13F-HR filings in Pactolio's tracked window.
- 686,473Shares Held (Latest Filing)
- $423.4MReported Market Value (Latest Filing)
- 13.7%Portfolio Weight (% of 13F Equity Book)
- 510,428Quarter-over-Quarter Share Change
- -$48.3MQuarter-over-Quarter Value Change
- 1,612,000Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 8 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 686,473 | 510,428 | -42.6% | $423.4M | 13.7% | $616.8 |
| Q1 2026 | 1,196,901 | +44,295 | +3.8% | $471.8M | 15.8% | $394.1 |
| Q4 2025 | 1,152,606 | 46,289 | -3.9% | $362.9M | 10.0% | $314.8 |
| Q3 2025 | 1,198,895 | +272,896 | +29.5% | $294.4M | 8.4% | $245.5 |
| Q2 2025 | 925,999 | 686,001 | -42.6% | $255.9M | 9.8% | $276.4 |
| Q1 2025 | 1,612,000 | +169,931 | +11.8% | $292.1M | 14.4% | $181.2 |
| Q4 2024 | 1,442,069 | +779,357 | +117.6% | $244.7M | 14.2% | $169.7 |
| Q3 2024 | 662,712 | – | – | $105.8M | 5.6% | $159.6 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did SurgoCap Partners LP first disclose a CRS position in 13F-HR filings?
SurgoCap Partners LP first reported CARPENTER TECHNOLOGY CORP (CRS) on its 13F-HR filing for the period ending 2024-09-30 (Q3 2024). The position has appeared on 8 reported quarters within Pactolio's tracked window.
What was SurgoCap Partners LP's most recent quarter-over-quarter share-count change in CRS?
Between Q1 2026 and Q2 2026, SurgoCap Partners LP reduced its CRS position by 510,428 shares (-42.6%), leaving 686,473 shares at a market value of $423.4M.
Does the implied price-per-share represent SurgoCap Partners LP's cost basis in CRS?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.